Clinical Trial Update: Effectiveness and Safety of Yisaipu Combined With Tripterygium Wilfordii for Active RA [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effectiveness and safety of Yisaipu combined with Tripterygium wilfordii for active rheumatoid arthritis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Tripterygium wilfordii (Tripterygium wilfordii)
• Yisaipu (etanercept biosimilar (assumed; if Yisaipu is a biosimilar of etanercept, otherwise provide as given))

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Arthritis, Rheumatoid | Phase 4 | Status: COMPLETED